Evidence map›Paper›PMID 35178484›Full record

ArticleCirculation reports2022

Oral Administration of

Masahiko Umei, Hiroshi Akazawa, Akiko Saga-Kamo, Hiroki Yagi, Qing Liu, Ryo Matsuoka, Hiroshi Kadowaki, Akito Shindo, Ayaka Nakashima, Kosuke Yasuda and 2 more

Open access · diamondAbstract read
In one paragraph

Article in Circulation reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.3field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 2 countries.

Masahiko UmeiDepartment of Cardiovascular Medicine, Graduate School of Medicine, The University of Tokyo Tokyo Japan.
Hiroshi AkazawaDepartment of Cardiovascular Medicine, Graduate School of Medicine, The University of Tokyo Tokyo Japan.
Akiko Saga-KamoDepartment of Cardiovascular Medicine, Graduate School of Medicine, The University of Tokyo Tokyo Japan.
Hiroki YagiDepartment of Cardiovascular Medicine, Graduate School of Medicine, The University of Tokyo Tokyo Japan.
Qing LiuDepartment of Cardiovascular Medicine, Graduate School of Medicine, The University of Tokyo Tokyo Japan.
Ryo MatsuokaDepartment of Cardiovascular Medicine, Graduate School of Medicine, The University of Tokyo Tokyo Japan.
Hiroshi KadowakiDepartment of Cardiovascular Medicine, Graduate School of Medicine, The University of Tokyo Tokyo Japan.
Akito ShindoDepartment of Cardiovascular Medicine, Graduate School of Medicine, The University of Tokyo Tokyo Japan.
Ayaka NakashimaEuglena Co. Ltd. Tokyo Japan.
Kosuke YasudaEuglena Co. Ltd. Tokyo Japan.
Kengo SuzukiEuglena Co. Ltd. Tokyo Japan.
Issei KomuroDepartment of Cardiovascular Medicine, Graduate School of Medicine, The University of Tokyo Tokyo Japan.
The University of Tokyo · JPManx National Heritage · IM

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Cardiac dysfunctionConstipationEuglenaIsoproterenolMouse model

Identifiers

PMID35178484
PMCPMC8811226
OpenAlexW4200067470

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.